PT-141 60mg — Vial Spec, Reconstitution Math & COA

Overview of PT-141 60mg Vial Specifications and Sourcing

A 60mg vial of PT-141 (Bremelanotide) contains a solid, lyophilized cake composed of 60 milligrams of highly purified synthetic peptide alongside stabilizing excipients optimized for rapid aqueous reconstitution. This expanded vial mass is tailored specifically for high-volume research applications, including multi-subject rodent behavioral studies, receptor binding kinetics, and automated high-content screening assays where reconstituting numerous lower-mass vials introduces unnecessary procedural variance.

When managing large-scale preclinical trials, utilizing a single 60mg mass lot minimizes container-closure variable factors and standardizes baseline reagent concentration across extensive sample cohorts. However, research facility protocols must account for the high concentration of reconstituted material to prevent premature enzymatic degradation or unintended aggregation during storage. If PX1 Research does not currently list an exact 60mg single-vial configuration on the active storefront, institutions can source equivalent mass allocations through our standard PT-141 10mg single-vial offerings or explore custom bulk fulfillment via our complete all-peptides catalog.

Melanocortin Receptor Binding Dynamics and Preclinical Pathways

PT-141 is a synthetic cyclic heptapeptide analog derived from Alpha-Melanocyte Stimulating Hormone (α-MSH). In preclinical literature, PT-141 functions as a non-selective melanocortin receptor agonist, exhibiting primary binding affinity for the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptor subtypes, with secondary activity at MC1R. Unlike peripheral vascular modulators, PT-141 acts directly within the central nervous system, specifically engaging melanocortin pathways located within the hypothalamus.

In vitro functional assays demonstrate that binding of PT-141 to MC3R and MC4R triggers G-protein coupled receptor (GPCR) signal transduction pathways, activating adenylyl cyclase and driving intracellular cyclic adenosine monophosphate (cAMP) accumulation. Animal models investigating central autonomic and behavioral responses demonstrate that this central melanocortin signaling cascade directly modulates neuroendocrine circuits involved in sexual-health pathways and appetitive behaviors. Preclinical studies suggest that the functional activity of PT-141 relies heavily on its central mechanism of action rather than peripheral nitric oxide pathways, making it a critical reference compound for mapping hypothalamic receptor networks.

60mg High-Volume Mass vs. Standard 10mg Vial Configurations

Selecting the appropriate peptide fill size is a fundamental decision in experimental design. A high-mass 60mg vial format is ideal for laboratory teams running continuous, automated fluidic protocols or large rodent cohorts where hundreds of micro-dose aliquots are administered over a condensed experimental timeframe. Reconstituting a single high-mass vial reduces plasticware waste, minimizes pipette transfer errors, and ensures identical baseline compound identity across all experimental subjects.

Conversely, for localized pilot studies, sporadic assays, or initial receptor affinity binding runs, lower fill sizes such as 10mg vials are frequently preferable. A 60mg reconstituted solution generates a high volumetric yield that must be utilized rapidly or frozen into single-use aliquots to preserve structural integrity. If a laboratory lacks deep-freeze storage (-80°C) or conducts low-frequency testing, smaller unit sizes mitigate the risk of potency loss secondary to repeated freeze-thaw degradation. Researchers evaluating alternative vial capacities can utilize our automated reconstitution calculator to determine the exact volume requirements for various mass configurations.

Precision Reconstitution Calculations for 60mg Lyophilized Mass

Reconstituting a 60mg mass of PT-141 requires precise calculation of diluent volume to achieve the desired working concentration (mg/mL or µg/µL). Because 60mg represents a substantial mass of peptide powder, investigators must ensure adequate diluent volume to achieve complete dissolution without exceeding the volumetric limits of standard laboratory storage micro-vials.

Below are standard mathematical conversions for reconstituting a 60mg PT-141 vial across common laboratory diluent volumes:

1. Reconstitution with 1.0 mL Diluent: Yields a final concentration of 60.0 mg/mL (60.0 µg/µL). This creates a highly concentrated stock solution suited for low-volume micro-injection setups or master stock storage.

2. Reconstitution with 2.0 mL Diluent: Yields a final concentration of 30.0 mg/mL (30.0 µg/µL). This provides a balanced concentration for general benchtop liquid handling systems.

3. Reconstitution with 3.0 mL Diluent: Yields a final concentration of 20.0 mg/mL (20.0 µg/µL). This concentration simplifies working dilutions when target experimental dosages fall within the lower microgram range.

4. Reconstitution with 6.0 mL Diluent: Yields a final concentration of 10.0 mg/mL (10.0 µg/µL). Recommended when high volumetric accuracy is required for manual micropipetting in animal model dosing.

Aliquot Planning, Storage Protocols, and Degradation Kinetics

Lyophilized PT-141 powder maintains high structural stability when stored in a desiccated environment at -20°C or -80°C, protected from direct light exposure. Under these conditions, the un-reconstituted peptide remains stable for extended shelf-life windows. Once reconstituted with a sterile aqueous diluent—such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS)—the peptide enters a dynamic aqueous state vulnerable to chemical degradation.

Aqueous peptide solutions undergo slow hydrolysis, oxidation, and deamidation over time, processes that accelerate rapidly when exposed to ambient temperatures or repeated freeze-thaw cycles. To maximize stock stability, research personnel should immediately divide the primary 60mg reconstituted solution into single-use micro-aliquots using sterile, low-binding polypropylene tubes. Working aliquots intended for use within 7 to 14 days should be kept stored at 2°C to 8°C. Long-term storage of aliquots requires rapid freezing at -80°C; frozen aliquots should be thawed once on ice immediately prior to assay execution and never re-frozen.

Analytical Certificate of Analysis (COA): HPLC, MS, and Endotoxin Limits

Every production lot of PT-141 synthesized for PX1 Research undergoes strict third-party analytical testing at accredited ISO 17025 facilities to confirm structural purity, mass identity, and microbiological safety. The batch-specific Certificate of Analysis serves as the definitive baseline verification document for analytical transparency.

High-Performance Liquid Chromatography (HPLC) is employed to quantify chromatographic purity, verifying that the main peak area accounts for ≥98.0% of total integrated UV absorbance. Liquid Chromatography-Mass Spectrometry (LC-MS) confirms the exact molecular weight and amino acid Sequence identity of the synthetic heptapeptide, ruling out truncated sequences or synthesis impurities. Furthermore, because in vivo preclinical research requires strictly controlled parenteral reagents, every fill lot undergoes Limulus Amebocyte Lysate (LAL) chromogenic testing to ensure endotoxin levels remain beneath strict threshold limits (<0.01 EU/mg). Researchers can review sample analytical reports directly on our dedicated COA documentation page.

Comparative Analysis: PT-141, Melanotan II, and Related Analogues

To contextualize the signaling profile of PT-141 within melanocortin receptor research, investigators frequently compare its receptor binding affinities against structural analogues within the same peptide class. The most common comparator compounds include Melanotan II and endogenous alpha-MSH fragments.

While Melanotan II (MT-2) features a similar cyclic structure, it possesses high affinity for the MC1R receptor, inducing significant melanogenesis alongside central melanocortin signaling. PT-141 (Bremelanotide) represents a hydroxylated metabolite derivative engineered to minimize MC1R-mediated pigmentary pathways while maintaining potent central MC3R and MC4R receptor agonism. Understanding these binding differentials allows researchers to select the precise agonist required for isolating central neuroendocrine pathways versus peripheral responses. For comprehensive literature reviews covering comparative receptor kinetics, consult our research library hub.

Laboratory Solubilization and Buffer Compatibility Rules

Proper solubilization techniques are critical to avoiding protein denaturation, aggregation, or precipitation during reconstitution of a 60mg cake. When introducing diluent into the glass vial, the stream of liquid should be directed gently down the interior glass wall rather than directly onto the lyophilized mass. Direct high-velocity impact can shear delicate peptide chains.

Allow the diluent to fully wet the powder cake for 2 to 3 minutes, followed by gentle side-to-side swirling. Vortexing, violent shaking, or sonicating the solution must be strictly avoided, as mechanical agitation introduces air bubbles and shear stress that disrupt peptide tertiary structures. Diluent compatibility includes standard Bacteriostatic Water for extended multi-entry laboratory use, Sterile Normal Saline (0.9% NaCl) for immediate isotonic animal assays, and PBS (pH 7.4) for cell culture and receptor binding assays.

Institutional Procurement, QC Integration, and Bulk Accounts

Academic institutions, biotechnology organizations, and contract research organizations (CROs) require reliable supply chain continuity when conducting multi-phase experimental trials. Standardizing procurement on high-purity, USA-manufactured research peptides ensures reproducibility across different experimental blocks and laboratory technicians.

PX1 Research maintains rigorous quality control standards across all synthesized lots, providing verified documentation, same-day dispatch from our California and Arizona logistics facilities, and direct account management for high-volume orders. Principal investigators and lab managers requiring structured supply contracts or multi-vial custom fill sizes are encouraged to establish an institutional profile through our wholesale account portal.